Cancer Institute Clinical Trials - Lung
#71120 NCT00324805
Title: A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with completely Resected IB IB (>/= 4cm) - IIIA Non-Small Cell Lung Cancer
Study Location: Temple Main Campus
#81727 NCT00693992
Title: Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patient Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer
Study Location: Temple Main Campus
#81885 NCT00918203
Title: The primary objective of this study is to evaluate the progression-free survivial (PFS) in previously untreated patients with Stage IIIB/IV non-small cell lung cancer (NSCLC) treated with IMC-3G3 plus paclitaxel and carboplatin (Arm A) versus paclitaxel and carboplatin (Arm B) in the first-line metastatic setting
Study Location: Temple Main Campus
#90336 NCT00828139
Title: A Randomized Phase II Trial of Weekly Topotecan With and Without AVE0005 in Patients with Platinum Treated Extensive Stage Small Cell Lung Cancer
Study Location: Temple Main Campus
#100060 NCT01137968
Title: A Randomized Phase II Study of Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy for Advance NOn-small Cell Lung Cancer (NSCLC)
Study Location: Temple Main Campus
For more information or to enroll in a study please call: 1-254-724-5407
